Breast Cancer News
-
Puma Biotechnology Inc., the maker of an experimental cancer drug, had its biggest two-day gain in seven months after data on a competitor medicine did nothing to diminish analysts’ expectations.
-
Should patients undergoing broad DNA testing for a specific ailment be told of unexpected findings that signal risk of cancer or other serious diseases, even if they don’t request the information?
-
AstraZeneca Plc will move three experimental cancer treatments into late-stage development as generic competition for its best-selling drugs intensifies.
-
Chemotherapy, radiation and the use of radioactive follow-up tests aren’t needed for some cancers, according to two studies that add to a growing debate on ways to lessen side effects and lower patient costs.
-
Angelina Jolie’s decision to have a double mastectomy is fueling debate among the thousands of women at risk of developing breast cancer who want to know how, if and when to have their breasts removed.
-
Angelina Jolie, named the highest- paid actress in Hollywood by Forbes in 2011, said she had a double mastectomy after learning she has a gene mutation linked to breast cancer, the disease that killed her mother at age 56.
-
Deborah Bernstein, who worked at Goldman Sachs Group Inc., Pequot Capital Management Inc. and Aquiline Capital Partners LLC in the 15 years since she graduated from Stanford University’s business school, has died. She was 41.
-
Just as Novartis AG’s best-selling medicines are losing patent protection, the company is poised to get a revenue boost from a U.S. program designed to speed life- saving therapies to patients with few treatment options.
-
Richard Perry, president of Perry Partners LP and chairman of Barneys New York, was in his very red library last night when he pulled out a copy of Life magazine from 1964.
-
An analysis of the most common uterine cancer suggests the disease should be reclassified into four categories that may help lead to more targeted treatments.
|
|
Most Popular on Bloomberg
|
| |